NasdaqGS - Delayed Quote USD

ScanSource, Inc. (SCSC)

40.50 +0.42 (+1.05%)
At close: April 18 at 4:00 PM EDT

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 3333
Avg. Estimate 0.860.963.444.04
Low Estimate 0.770.893.383.92
High Estimate 0.91.043.484.16
Year Ago EPS 0.960.763.853.44

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 3333
Avg. Estimate 829.41M929.81M3.61B3.79B
Low Estimate 821.6M897.2M3.5B3.71B
High Estimate 843.1M956.62M3.8B3.88B
Year Ago Sales --947.15M3.79B3.61B
Sales Growth (year/est) ---1.80%-4.70%5.00%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.910.750.90.97
EPS Actual 0.960.760.740.85
Difference 0.050.01-0.16-0.12
Surprise % 5.50%1.30%-17.80%-12.40%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.860.963.444.04
7 Days Ago 0.860.963.444.04
30 Days Ago 0.860.963.444.04
60 Days Ago 0.921.043.624.07
90 Days Ago 0.91.13.714.22

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD SCSCIndustrySectorS&P 500
Current Qtr. -10.40%----0.80%
Next Qtr. 26.30%----9.60%
Current Year -10.60%----4.50%
Next Year 17.40%----13.30%
Next 5 Years (per annum) 14.00%----11.09%
Past 5 Years (per annum) 9.87%------

Research Analysis

Analyst Price Targets

39.00 Low
41.50 Average
40.50 Current
44.00 High

Fair Value

Near Fair Value
% Return
40.50 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Downgrade Northcoast Research: Buy to Neutral 12/19/2023
Maintains Raymond James: Outperform to Outperform 11/10/2023
Upgrade Northcoast Research: Neutral to Buy 8/23/2023
Maintains Raymond James: Outperform 11/9/2022
Maintains Raymond James: Outperform 11/10/2021
Maintains Raymond James: Outperform 8/25/2021

Related Tickers